AVIDITY BIOSCIENCES INC (RNA)
US05370A1088 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 471.40M | 185.08M | 340.40M | 320.40M | 321.50M | |||
| Marketable Securities | 444.47M | 410.27M | 270.30M | 85.10M | 6.70M | |||
| Receivables | 1.57M | 1.10M | N/A | N/A | N/A | |||
| Other Current Assets | 17.03M | 14.85M | 12.20M | 5.60M | 3.50M | |||
| Total Current Assets | 934.47M | 611.31M | 622.90M | 411.10M | 331.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.28M | 16.65M | 15.00M | 15.60M | 1.90M | |||
| Other Non-Current Assets | 720.00K | 596.00K | 800.00K | 900.00K | 300.00K | |||
| Total Non-Current Assets | 17.00M | 17.25M | 15.90M | 16.50M | 2.20M | |||
| TOTAL ASSETS | 951.47M | 628.55M | 638.80M | 427.60M | 333.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 46.50M | 43.51M | 14.30M | 10.70M | 3.20M | |||
| Accounts Payable | 2.35M | 8.81M | 32.60M | 14.10M | 7.70M | |||
| Other Current Liabilities | 26.10M | 28.36M | 5.00M | 4.90M | 3.70M | |||
| Total Current Liabilities | 74.95M | 80.68M | 51.90M | 29.70M | 14.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 45.62M | 47.11M | 8.80M | 16.50M | 13.10M | |||
| Total Non-Current Liabilities | 45.62M | 47.11M | 8.80M | 16.50M | 13.10M | |||
| TOTAL LIABILITIES | 120.58M | 127.79M | 60.70M | 46.20M | 27.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -639.62M | -570.76M | -358.50M | -184.50M | -66.50M | |||
| Additional Paid In Capital | 1.47B | 1.07B | 939.30M | 566.20M | 372.80M | |||
| Common Shares | 10.00K | 8.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -464.00K | 125.00K | -2.70M | -200.00K | 0.00 | |||
| Shares Outstanding | 95.59M | 79.28M | 69.80M | 47.80M | 37.60M | |||
| Tangible Book Value per Share | 8.69 | 6.32 | 8.28 | 7.98 | 8.14 | |||
| Total Shareholders' Equity | 830.90M | 500.76M | 578.10M | 381.40M | 306.20M | |||
| TOTAL LIABILITIES AND EQUITY | 951.47M | 628.55M | 638.80M | 427.60M | 333.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 12.47 | 7.58 | 12.00 | 13.84 | 22.72 | |||
| Return On Assets (ROA) | -24.04% | -33.76% | -27.24% | -27.60% | -13.29% | |||
| Return On Equity (ROE) | -27.52% | -42.38% | -30.10% | -30.94% | -14.49% | |||
All data in USD